Acro Biomedical Co., Ltd. (ACBM)

0.1050 0.0000 (0.00%) At close: 02:16PM EDT

Acro Biomedical Co., Ltd.

12175 Visionary Way
Suite 1160
Fishers, IN 46038
United States
317 286 6788
https://acrobiomedicalco.com

Sector(s): Healthcare
Industry: Medical Distribution
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Pao-Chi Chu	CEO, CFO, President, Secretary & Director	N/A	N/A	1954
Mr. Jer-Li Lin	Vice President of Technical	N/A	N/A	N/A
Mr. Cheng-Hsiang Kao	Managing Director	N/A	N/A	N/A
Mr. An-Tao Fong	Managing Director	N/A	N/A	N/A
Mr. Yun-Yuan Chu	Managing Director	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Acro Biomedical Co., Ltd. engages in the development and marketing of nutritional products. It is involved in the development and sale of cordyceps, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.

Corporate governance

Acro Biomedical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.